DK0405342T3 - (1,2,3,4-Tetrahydro-9-acridinimino)cyclohexancarboxylsyre og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler - Google Patents

(1,2,3,4-Tetrahydro-9-acridinimino)cyclohexancarboxylsyre og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Info

Publication number
DK0405342T3
DK0405342T3 DK90111814.1T DK90111814T DK0405342T3 DK 0405342 T3 DK0405342 T3 DK 0405342T3 DK 90111814 T DK90111814 T DK 90111814T DK 0405342 T3 DK0405342 T3 DK 0405342T3
Authority
DK
Denmark
Prior art keywords
acridinimino
tetrahydro
drugs
preparation
related compounds
Prior art date
Application number
DK90111814.1T
Other languages
Danish (da)
English (en)
Inventor
Joseph Francis Payack
Lawrence Leo Martin
Helen Hu Ong
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Application granted granted Critical
Publication of DK0405342T3 publication Critical patent/DK0405342T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK90111814.1T 1989-06-26 1990-06-22 (1,2,3,4-Tetrahydro-9-acridinimino)cyclohexancarboxylsyre og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler DK0405342T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/371,228 US4999358A (en) 1989-06-26 1989-06-26 (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds

Publications (1)

Publication Number Publication Date
DK0405342T3 true DK0405342T3 (da) 1995-05-15

Family

ID=23463058

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90111814.1T DK0405342T3 (da) 1989-06-26 1990-06-22 (1,2,3,4-Tetrahydro-9-acridinimino)cyclohexancarboxylsyre og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler

Country Status (17)

Country Link
US (1) US4999358A (no)
EP (1) EP0405342B1 (no)
JP (1) JP2600013B2 (no)
KR (1) KR0163186B1 (no)
AT (1) ATE115133T1 (no)
AU (1) AU625221B2 (no)
CA (1) CA2019717C (no)
DE (1) DE69014730T2 (no)
DK (1) DK0405342T3 (no)
ES (1) ES2064533T3 (no)
FI (1) FI96307C (no)
IE (1) IE65462B1 (no)
IL (3) IL94854A (no)
NO (1) NO177053C (no)
NZ (1) NZ234199A (no)
PT (1) PT94472B (no)
ZA (1) ZA904914B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640508B1 (fr) * 1988-12-19 1994-07-01 Dietlin Francois Nouvelles compositions et nouveaux produits pharmaceutiques assurant la regeneration de leucocytes et leur emploi pour le traitement du syndrome immuno-deficitaire
US5149813A (en) * 1989-06-26 1992-09-22 Hoechst-Roussel Pharmaceuticals Incorporated Process for (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds
US6100276A (en) * 1996-04-12 2000-08-08 Aventis Pharmaceuticals Inc. Isatin derivatives as acetylcholinesterase inhibitors and analgesics
EP0840770A4 (en) * 1996-05-23 2002-03-20 Ian Alexander Gilmour PROCESS FOR THE EXTRACTION OF PROANTHOCYANIDINES FROM BOTANICAL SUBSTANCES
EP1891954A3 (en) 1998-09-30 2009-01-14 Takeda Pharmaceutical Company Limited Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
US8328939B2 (en) * 2004-05-12 2012-12-11 Applied Materials, Inc. Diffuser plate with slit valve compensation
US9221760B2 (en) * 2011-05-09 2015-12-29 Van Andel Research Institute Autophagy inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB595603A (en) * 1944-08-21 1947-12-10 Ward Blenkinsop & Co Ltd Process for the production of arylamino acridine derivatives
EP0268871A1 (en) * 1986-10-31 1988-06-01 Sumitomo Pharmaceuticals Company, Limited Quinoline derivatives
US4851536A (en) * 1987-05-07 1989-07-25 American Home Products Corporation Cyclohexylquinolines as inhibitors of interleukin 1
EP0306826A1 (en) * 1987-09-08 1989-03-15 Hoechst-Roussel Pharmaceuticals Incorporated N-(substituted alkylidene)fused bicycloalkylidene and hetero-alkylidene quinolinamines, a process for their preparation and their use as medicaments
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives

Also Published As

Publication number Publication date
JP2600013B2 (ja) 1997-04-16
US4999358A (en) 1991-03-12
NO902813D0 (no) 1990-06-25
JPH0395161A (ja) 1991-04-19
KR0163186B1 (ko) 1998-12-01
FI96307B (fi) 1996-02-29
IL107001A0 (en) 1993-12-28
NO177053B (no) 1995-04-03
CA2019717A1 (en) 1990-12-26
IL94854A0 (en) 1991-04-15
KR910000652A (ko) 1991-01-29
IL107001A (en) 1994-10-21
DE69014730T2 (de) 1995-05-11
AU625221B2 (en) 1992-07-02
IL94854A (en) 1994-08-26
ES2064533T3 (es) 1995-02-01
ATE115133T1 (de) 1994-12-15
FI903181A0 (fi) 1990-06-25
EP0405342B1 (en) 1994-12-07
DE69014730D1 (de) 1995-01-19
NO177053C (no) 1995-07-12
IE902290A1 (en) 1991-01-16
EP0405342A1 (en) 1991-01-02
NO902813L (no) 1990-12-27
PT94472B (pt) 1997-05-28
PT94472A (pt) 1991-02-08
AU5775390A (en) 1991-01-03
IE902290L (en) 1990-12-26
ZA904914B (en) 1992-02-26
IE65462B1 (en) 1995-11-01
FI96307C (fi) 1996-06-10
NZ234199A (en) 1992-05-26
CA2019717C (en) 2001-01-23

Similar Documents

Publication Publication Date Title
DK441187A (da) Alfa-alkyl-4-amino-3-quinolinmethanoler og 1-(4-aralkylamino-3-quinolinyl)alkanoner, deres fremstilling og anvendelse
DK0420140T3 (da) N-Aminocarbamater beslægtede med physostigmin, en fremgangsmåde til deres fremstilling og deres anvedelse som lægemidler
DK0405342T3 (da) (1,2,3,4-Tetrahydro-9-acridinimino)cyclohexancarboxylsyre og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK613687A (da) Kondenserede heterocycliske tetrahydroaminoquinolinoler og beslaegtede forbindelser, fremgangsmaade til deres fremstilling og deres anvendelse som laegemidler
DK662189A (da) Pyridinylcarbazolaminer, deres fremstilling og anvendelse som laegemidler
DK0401779T3 (da) 4,5,5a,6-Tetrahydro-3H-isoazolo(5,4,3-kl)acridinderivater, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK114386A (da) Benzo(c)-1,5-naphthyridiner, fremgangsmaade og mellemprodukter til fremstilling deraf og deres anvendelse som laegemidler